The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Plasma triglyceride and coronary heart disease
Open accessAbstract
Although the literature on epidemiological associations between plasma triglyceride and CHD is not completely consistent, trends do emerge from the studies described here. First, the majority of observational studies demonstrate a significant univariate relation, although the results of case-control and cross-sectional studies are more uniform than those from prospective study designs. In many but not all studies, triglyceride remains a significant predictor of CHD in multivariate statistical analyses after controlling for TC or LDL-C. Perhaps the least consistent result is that the triglyceride association does not persist in some analyses controlling for HDL-C, while in other studies, the association remains significant. Although most studies have been conducted in men, the studies providing data on women, normocholesterolemic subjects, and diabetic subjects have generally found triglyceride to be, at the very least, a univariate risk factor. The results of intervention trials differ considerably, but no such study to date has been specifically designed to evaluate triglyceride-lowering effects on primary prevention of CHD. Important statistical properties must be taken into consideration in evaluating triglyceride as a risk factor for CHD. The large variability of triglyceride measurements and the correlation of triglyceride values with other lipid measures appears to result in the underestimation of the association between triglyceride and disease in multivariate analyses. Finally, individual genetic susceptibility may play an important role in the relation between plasma triglyceride levels and CHD. For example, risk of CHD clearly varies among the well-established familial forms of hypertriglyceridemia. A predominance of small, dense, LDL particles (LDL subclass pattern B) also appears to be a genetic trait associated with both increased risk of MI and increases in plasma triglyceride levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent advances in human genetics, together with a large body of epidemiologic, preclinical, and clinical trial results, provide strong support for a causal association between triglycerides (TG), TG-rich lipoproteins (TRL), and TRL remnants, and increased risk of myocardial infarction, ischaemic stroke, and aortic valve stenosis.”
In the citing paper
“Over the past three decades, epidemiologic and genetic evidence has accumulated to support the concept that elevated levels of plasma TG, TRL, and TRL remnants are causally related to an increased risk of ASCVD-related events—myocardial infarction (MI), stroke, and aortic valve stenosis—and all-cause mortality.1,2,17,19,20,24–28”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Meade, T. W., Brozović, M., Chakrabarti, R., Haines, A., Imeson, J., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,937
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Self-citationMorbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study
Garcia, M. J., McNamara, P. M., Gordon, T., & Kannell, W. B. (1974) · Diabetes · doi:10.2337/diab.23.2.105 · Cited by 1,608
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., de Faire, U., Dahlén, G. H., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107332 · Cited by 1,444
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Self-citation
Flagged first, then by citations
Research works printed but not linked: 26
- [2]2. National Heart, Lung, and Blood Institute Consensus Development Panel: Treatment of hypertriglyceridemia. JAMA 1984;251:1196-1200
- [15]15. factors in relation to acute myocardial infarction. Arteriosclerosis 1981;1:273-279
- [30]30. Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetiere P, Claude JR: Is the level of serum triglyceride a it,, ot f oo teir olemic" subjects? The Paris Prospective Study. Am J Epidemiol 1986;124:624-632
- [29]29. Carlson LA, Böttiger LÈ: Risk factors for ischaemic heart disease in men and women. Acta Med Scand 1985;218:207–211
- [32]32. Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangiwala S: Triglycerides and coronary heart disease mortality: The Lipid Research Clinics Follow-up Study. Atheroscler Rev (in press)
- [34]34. Pocock SJ, Shaper AG, Phillips AN: Concentrations of high density lipoprotein cholesterol, triglyceride and total cholesterol in ischaemic heart disease. Br Med J 1989;298:998–1002
- [37]37. Wilson PF: The impact of triglycerides on coronary heart disease: The Framingham Study. Atherosclerosis Rev (in press)
- [4]4. Scand Suppl 1973;549:51–59
- [46]46. Salel AF, Riggs K, Mason DT, Amsterdam EA, Zelis R: The impdsie rea psie ia p psng factor in coronary artery disease. Am J Med 1974;57:897–903
- [50]50. Jenkins PJ, Harper RW, Nestel PJ: Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J 1978;2:388-391
- [53]53. Wieland H, Seidel D, Wiegand V, Kreuzer H: Serum lipoproteins and coronary artery disease (CAD). Atherosclerosis 1980;36:269-280
- [55]55. Holmes DR Jr, Elveback LR, Frye RL, Kottke BA, Ellefson RD: Association of risk factor variables and coronary artery disease documented with angiography. Circulation 1981;63: 293-299
- [58]58. Reardon MF, Nestel PJ, Craig IH, Harper RW: Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 1985;71:881-888
- [64]64. Santen RJ, Willis PW, Fajaris SS: Atherosclerosis in diabetes mellitus: Correlations with lipid levels, adiposity and serum insulin level. Arch Intern Med 1972;130:833–843
- [66]66. Janka HU: Five-year incidence of major macrovascular complications in diabetes mellitus. Horm Metab Res Suppl Series 1985;15:15-19
- [71]71. Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365-374
- [77]77. Kelsey J, Thompson WD, Evans AS: Methods in Observational Epidemiology. New York, Oxford University Press, 1986, pp 293–297
- [84]84. Davis CE, Kim H: Is triglyceride an independent risk factor for CHD? Circulation 1990;81:14
- [88]88. Childs B: Introduction, in Childs B, Holtzman NA, Kazazian HH, Valle DL (eds): Molecular Genetics in Medicine. Progress in Medical Genetics, New Series, Vol 7. New York, Elsevier, 1988, Pp 1-16
- [93]93. Mahley RW, Innerarity TL, Rall SC Jr, Weisbraber KH: Lipoproteins of special significance in atherosclerosis: Insights provided by studies of Type III hyperlipidemia. Ann N Y Acad Sci 1986;485:209–221
- [92]92. Sane T, Nikkila EA: Very low density lipoprotein triglyceride metabolism in relatives of hypertriglyceridemic probands. Arteriosclerosis 1987;8:217–226
- [97]97. Shen MMS, Krauss RM, Lindgren FT, Forte TM: Heterogeneity of serum low density lipoproteins in normal subjects. J Lipid Res 1981;22:236–244
- [99]99. Lindgren FT, Jensen LC, Hatch FT: The isolation and quantitative analysis of serum lipoproteins, In Nelson GJ (ed): Blood Lipids and Lipoproteins. New York, Wiley Interscience, 1972, pp 181–274
- [101]101. Eisenberg S, Gavish D, Oschry Y, Fainaru M, Deckelbaum RJ: Abnormalities in very low, low, and high density lipoproteins in hypertriglyceridemia. J Clin Invest 1984;74:470–482
- [102]102. Nichols AV, Krauss RM, Musliner TA: Nondenaturing polyacrylamide gradient gel electrophoresis, In Segrest JP, Albers JJ (eds): Methods in Enzymology, Plasma Lipoproteins. Part A. Preparation, Structure and Molecular Biology. Orlando, Fla, Academic Press, Inc, 1986, vol 41, pp 417–431
- [110]110. Gianturco SH, Bradley WA: A cellular basis for the atherogenicity of triglyceride-risk lipoproteins. Atherosclerosis Rev (in press)
Cited by
Sorted by citations
Items 101–200 of 696
Karpe, F., Bell, M., Björkegren, J., & Hamsten, A. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.2.199 · Cited by 143
Hydrogen Sulfide and the Pathogenesis of Atherosclerosis
Mani, S., Untereiner, A. A., Wu, L., & Wang, R. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5324 · Cited by 141
“Hypertriglyceridemia increased the risk for the formation of early lesions (3, 4).”
Epidemiology of hypertriglyceridemia and cardiovascular disease
Austin, M. A. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00209-x · Cited by 138
Self-citationElevated Serum Triglyceride Levels and Long-Term Mortality in Patients With Coronary Heart Disease
Haim, M., Benderly, M., Brunner, D., Behar, S., Graff, E., Reicher-Reiss, H., & Goldbourt, U. (1999) · Circulation · doi:10.1161/01.cir.100.5.475 · Cited by 138
Schmidt, E. B., & Dyerberg, J. (1994) · Drugs · doi:10.2165/00003495-199447030-00003 · Cited by 136
Hayek, T., Azrolan, N., Verdery, R. B., Walsh, A., Chajek‐Shaul, T., Agellon, L. B., Tall, A. R., & Breslow, J. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116683 · Cited by 133
“In humans there is a strong association between hypertriglyceridemia and low levels of HDLcholesterol (HDL-C)' and apo A-I, the principal HDLapolipoprotein (1-10).”
BackgroundTriglycerides and Risk for Coronary Heart Disease
McBride, P. E. (2007) · JAMA · doi:10.1001/jama.298.3.336 · Cited by 132
An update on coronary risk factors
Kannel, W. B., & Wilson, P. W. F. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30016-5 · Cited by 128
Freeman, D. J., Griffin, B. A., Murray, E. F., Lindsay, G. M., Gaffney, D. F., Packard, C. J., & SHEPHERD, J. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00724.x · Cited by 129
Lamarche, B., Després, J., Moorjani, S., Cantin, B., Dagenais, G. R., & Lupien, P.-J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05653-x · Cited by 129
Ginsberg, H. N., Jones, J., Blaner, W. S., Thomas, A., Karmally, W., Fields, L., Blood, D. K., & Begg, M. D. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1829 · Cited by 128
Andersen, R. V., Wittrup, H. H., Tybjærg‐Hansen, A., Steffensen, R., Schnohr, P., & Nordestgaard, B. G. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00407-8 · Cited by 127
“density lipoprotein (LDL), both of which may cause atherosclerosis (1,2).”
BackgroundAutoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus
Reichlin, M., Fesmire, J., Quintero‐Del‐Rio, A. I., & Wolfson‐Reichlin, M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10624 · Cited by 127
Grundy, S. M., Bazzarre, T. L., Cleeman, J. I., D’Agostino, R. B., Hill, M. N., Miller, N. H., Kannel, W. B., Krauss, R. M., Krumholz, H. M., Lauer, R. M., et al. (2000) · Circulation · doi:10.1161/01.cir.101.1.e3 · Cited by 127
Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis
Khalil, M. F., Wagner, W. D., & Goldberg, I. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000147163.54024.70 · Cited by 125
Shimada, M., Shimano, H., Gotoda, T., Yamamoto, K., Kawamura, M., Inaba, T., Yazaki, Y., & Yamada, N. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46793-7 · Cited by 125
Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia
Zavaroni, I., Mazza, S., Fantuzzi, M., Dall’Aglio, E., Bonora, E., Delsignore, R., Passeri, M., & Reaven, G. M. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00700.x · Cited by 122
Serum lipid levels in an Iranian adults population: Tehran lipid and glucose study
Azizi, F., Rahmani, M., Ghanbarian, A., Emami, H., Salehi, P., Mirmiran, P., & Sarbazi, N. (2003) · European Journal of Epidemiology · doi:10.1023/a:1023606524944 · Cited by 124
“For some specific population groups that include postmenopausal women, older men, and persons with low HDL-C level, TGs appears to play an independent role in the development of CAD [41].”
BackgroundClustering of cardiovascular risk factors: Targeting high-risk individuals
Genest, J. J., & Cohn, J. S. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80010-4 · Cited by 123
Ruel, G., Pomerleau, S., Couture, P., Lemieux, S., Lamarche, B., & Couillard, C. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061814 · Cited by 122
“There is a well-known inverse relationship between plasma TG and HDL-cholesterol concentrations (Austin, 1991); this is the result of the action of the cholesterol ester transfer protein, which leads to the TG enrichment and cholesterol impoverishment of HDL particles (Tall, 1986).”
BackgroundGuo, Z., Mitchell-Raymundo, F., Yang, H., Ikeno, Y., Nelson, J., Diaz, V., Richardson, A., & Reddick, R. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00008-8 · Cited by 121
Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation
Doi, H., Kugiyama, K., Ohgushi, M., Sugiyama, S., Matsumura, T., Ohta, Y., Nakano, T., Nakajima, K., & Yasue, H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00291-8 · Cited by 121
Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice
Yagyu, H., Ishibashi, S., Chen, Z., Osuga, J.-I., Okazaki, M., Perrey, S., Kitamine, T., Shimada, M., Ohashi, K., Harada, K., et al. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33414-3 · Cited by 120
Asplund-Carlson, A., Hamsten, A., Wiman, B., & Carlson, L. A. (1993) · Diabetologia · doi:10.1007/bf00400356 · Cited by 120
“The relationships between hypertriglyceridaemia and coronary heart disease (CHD) have been much discussed concerning both non-diabetic subjects as well as non-insulin-dependent diabetic patients [1-3].”
BackgroundCobbe, S. M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00863-6 · Cited by 118
Triglycerides and risk for coronary artery disease
McBride, P. E. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0060-9 · Cited by 119
An examination of the factors affecting intestinal lymphatic transport of dietary lipids
Nordskog, B. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00147-8 · Cited by 116
Triglycerides: a risk factor for coronary heart disease
Davignon, J., & Cohn, J. S. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05858-3 · Cited by 116
“with many methodological difficulties, which have been comprehensively reviewed by Austin [1].”
BackgroundImpact of chronic cigarette smoking on body composition and fuel metabolism
Jensen, E. X., Fusch, C., Jaeger, P., Peheim, E., & Horber, F. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608276 · Cited by 116
Wittrup, H. H., Tybjærg‐Hansen, A., Abildgaard, S., Steffensen, R., Schnohr, P., & Nordestgaard, B. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119323 · Cited by 114
“Because of this and because these two cardiovascular risk factors have been found to be independent predictors of ischemic heart disease, in the present and former studies (9, 10), the present data support the notion that the Asn291Ser substitution in lipoprotein lipase may represent a susceptibility mutation for isch…”
BackgroundResultColeman, T., Seip, R. L., Gimble, J. M., Lee, D., Maeda, N., & Semenkovich, C. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12518 · Cited by 113
Karpe, F., Fairé, U. D., Mercuri, M. F., BOND, M., Hellénius, M.-L., & Hamsten, A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00184-1 · Cited by 110
Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype
Austin, M. A. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0021-4 · Cited by 110
Self-citationGenetic Basis of Lipoprotein Disorders
Dammerman, M., & Breslow, J. L. (1995) · Circulation · doi:10.1161/01.cir.91.2.505 · Cited by 110
Layne, K. S., Goh, Y. K., Jumpsen, J., Ryan, E. A., Chow, P., & Clandinin, M. T. (1996) · Journal of Nutrition · doi:10.1093/jn/126.9.2130 · Cited by 109
Associations between serum lipids and indicators of adiposity in men with spinal cord injury
Maki, K. C., BRIONES, E. R., Langbein, W. E., Inman-Felton, A., Nemchausky, B. M., Welch, M., & Burton, J. (1995) · Spinal Cord · doi:10.1038/sc.1995.24 · Cited by 107
Gerstein, H. C., Pais, P. S., Pogue, J., & Yusuf, S. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00637-8 · Cited by 107
“The fact that the cholesterol/HDL ratio was an independent determinant of MI in the multivariate analysis of all subjects and the fact that triglyceride levels were not an independent determinant of MI is consistent with other epidemiologic studies (23,24).”
ResultPearce, K. L., Clifton, P. M., & Noakes, M. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510003983 · Cited by 109
“Age (years) 59·8 8·4 59·1 8·0 BMI (kg/m(2)) 33·4 4·6 34·8 5·0 Baseline wt (kg) 94·4 15·5 96·8 14·8 SBP (mmHg) 135·4 13·3 129·8 13·5 DBP (mmHg) 74·6 9·2 72·8 8·4 HbA1c (%) 7·0 1·0 7·0 1·0 Smokers (yes/ no) 0/31 1/33 Male/female (total) 13/18 (31) 16/18 (34) Lipid medication (yes/no) 14/17 13/21 Diabetes medication (yes…”
Lindman, A. S., Veierød, M. B., Tverdal, A., Pedersen, J. I., & Selmer, R. M. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9501-1 · Cited by 111
“Discrepancies between univariate and multivariable analyses in studies on CVD risk and triglycerides have been reported in many studies [4, 7, 8].”
BackgroundResultMarckmann, P., Sandström, B., & Jespersen, J. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.4.935 · Cited by 103
Genetics of type III hyperlipoproteinemia
Feussner, G., Piesch, S., Dobmeyer, J., & Fischer, C. (1997) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(1997)14:3 · Cited by 18
Self-citationMalmberg, K., Båvenholm, P., & Hamsten, A. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90002-7 · Cited by 102
Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: effects of energy intake
Kasim-Karakas, S. E., Almario, R. U., Mueller, W. M., & Peerson, J. M. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1439 · Cited by 101
“Although high plasma triacylglycerol concentrations are also associated with increased risk of CHD, this relation may be indirect and may be secondary to the decreased HDL-cholesterol and increased small-dense LDL concentrations that accompany hypertriacylglycerolemia (3, 4).”
BackgroundFibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors
Levenson, J., Giral, P., Razavian, M., Gariepy, J., & Simon, A. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.9.1263 · Cited by 152
Lipid profile of women with premature ovarian failure
Knauff, E. A. H., Westerveld, H. E., Goverde, A. J., Eijkemans, M. J. C., Valkenburg, O., van Santbrink, E. J. P., Fauser, B. C. J. M., & van der Schouw, Y. T. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31816b4509 · Cited by 100
Liver Enzyme Induction and Serum Lipid Levels After Replacement of Carbamazepine with Oxcarbazepine
Isojärvi, J. I. T., Pakarinen, A., Rautio, A., Pelkonen, O., & Myllylä, V. V. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb01792.x · Cited by 98
Kondo, A., Muranaka, Y., Ohta, I., Notsu, K., Manabe, M., Kotani, K., Saito, K., Maekawa, M., & Kanno, T. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.5.893 · Cited by 98
Karpe, F., Hellénius, M.-L., & Hamsten, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90076-8 · Cited by 97
Coronary Flow Reserve in Young Men With Familial Combined Hyperlipidemia
Pitkänen, O., Nuutila, P., Raitakari, O. T., Porkka, K., Iida, H., Nuotio, I. O., Rönnemaa, T., Viikari, J. S. A., Taskinen, M., Ehnholm, C., et al. (1999) · Circulation · doi:10.1161/01.cir.99.13.1678 · Cited by 97
Evidence for mechanisms of the hypotriglyceridemic effect of n − 3 polyunsaturated fatty acids
Surette, M. E., Whelan, J., Broughton, K. S., & Kinsella, J. E. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90291-3 · Cited by 97
Gaudet, D., Vohl, M., Perron, P., Tremblay, G., Gagné, C., Lesiège, D., Bergeron, J., Moorjani, S., & Després, J. (1998) · Circulation · doi:10.1161/01.cir.97.9.871 · Cited by 99
“However, in the FH patients of the present study, fasting TG concentration was not independently associated with CAD, a finding generally consistent with most of the literature on non-FH patients.(45) The increased CAD risk associated with abdominal obesity and hyperinsulinemia found in FH patients of the present stud…”
ResultMégnien, J. L., Sene, V., Jeannin, S., Hernigou, A., Plainfosse, M. C., Merli, I. P., Atger, V., MOATTI, N., Levenson, J. A., & Simon, A. C. (1992) · Circulation · doi:10.1161/01.cir.85.5.1799 · Cited by 96
Mathiesen, E. B., Bønaa, K. H., & Joakimsen, O. (2001) · Stroke · doi:10.1161/hs0901.095639 · Cited by 95
Serum Lipid Levels During Carbamazepine Medication
Isojärvi, J. I. T. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540060030012 · Cited by 94
Insull, W. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00615-8 · Cited by 94
Steiner, G. (1996) · Diabetologia · doi:10.1007/s001250050630 · Cited by 110
“There is debate about whether the risk effect of hypertriglyceridaemia is, or is not dependent on associated low levels of HDL-cholesterol [6].”
BackgroundInfluentialMenopause Is Associated With Reduced Protection From Postprandial Lipemia
van Beek, A. P., de Ruijter-Heijstek, F. C., Erkelens, D. W., & de Bruin, T. W. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.11.2737 · Cited by 91
Giral, P., Bruckert, É., Jacob, N., Chapman, M. J., Foglietti, M. J., & Turpin, G. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00474-3 · Cited by 92
Wolfe, M. L., Vartanian, S. F., Ross, J. L., Bansavich, L.-L., Mohler, E. R., Meagher, E. A., Friedrich, C. A., & Rader, D. J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01410-7 · Cited by 91
Forsblom, C. M., Eriksson, J. G., Ekstrand, A., TEPPO, A. M., Taskinen, M., & Groop, L. (1995) · Diabetologia · doi:10.1007/bf00400643 · Cited by 88
“First, triglyceride concentrations show larger variability both within and between individuals than HDL-cholesterol concentrations [35].”
BackgroundIndividuals with high total cholesterol/hdl cholesterol ratios are insulin resistant
Jeppesen, Facchini, & Reaven (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00301.x · Cited by 89
Facchini, F. S., Carantoni, M., Jeppesen, J., & Reaven, G. M. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90121-4 · Cited by 85
Muros, M., & Rodríguez-Ferrer, C. R. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)06643-8 · Cited by 87
Varbo, A., Benn, M., Tybjærg‐Hansen, A., Grande, P., & Nordestgaard, B. G. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.216333 · Cited by 86
Insulin resistance and risk factors for coronary heart disease
Laws, A., & Reaven, G. M. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80245-9 · Cited by 87
Lipid Peroxides as the Initiating Factor of Atherosclerosis
NATTO, C., Kawamura, M., & Yamamoto, Y. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb38723.x · Cited by 85
McKeone, B. J., Patsch, J. R., & Pownall, H. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116411 · Cited by 84
Do Triglycerides Provide Meaningful Information About Heart Disease Risk?
Avins, A. L., & Neuhaus, J. M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.13.1937 · Cited by 80
McCollum Award Lecture, 1993: Triglyceride-rich lipoproteins and atherosclerosis—new perspectives
Havel, R. J. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.4.795 · Cited by 87
Warden, C. H., Fisler, J. S., Pace, M. J., Svenson, K. L., & Lusis, A. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116649 · Cited by 83
Baroni, M. G., D’Andrea, M. P., Montali, A., Pannitteri, G., Barillà, F., Campagna, F., Mazzei, E. M. E., Lovari, S., Seccareccia, F., Campa, P. P., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.12.2975 · Cited by 83
Levak‐Frank, S., Weinstock, P. H., Hayek, T., Verdery, R. B., Hofmann, W. E., Ramakrishnan, R., Sattler, W., Breslow, J. L., & Zechner, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17182 · Cited by 81
Interactions Between Glucose and FFA Metabolism in Man
Saloranta, C., & Groop, L. (1996) · Diabetes/Metabolism Reviews · doi:10.1002/(sici)1099-0895(199603)12:1 · Cited by 37
Onat, A., Sarı, İ., Yazıcı, M., Can, G., Hergenç, G., & Avcı, G. Ş. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.06.056 · Cited by 80
“first meta-analysis on this subject [2] was noted that most analyses showed a relation between triglycerides and CHD, the evidence for a causal relation with CHD was found incomplete [3].”
BackgroundTybjærg‐Hansen, A., Nordestgaard, B. G., Gerdes, L. U., Færgeman, O., & Humphries, S. E. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90202-6 · Cited by 81
Huang, Y., Li, W., Dong, L., Li, R., & Wu, Y. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14001 · Cited by 76
Austin, M. A., & Hokanson, J. E. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30178-x · Cited by 78
Self-citationBurchfiel, C. M., Laws, A., Benfante, R., Goldberg, R. J., Hwang, L., Chiu, D., Rodríguez, B. L., Curb, J. D., & Sharp, D. S. (1995) · Circulation · doi:10.1161/01.cir.92.6.1430 · Cited by 78
Mahdavi‐Roshan, M., Mozafarihashjin, M., Shoaibinobarian, N., Ghorbani, Z., Salari, A., Savarrakhsh, A., & Hekmatdoost, A. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01732-9 · Cited by 77
Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease
Després, J., Lemieux, I., & Robins, S. J. (2004) · Drugs · doi:10.2165/00003495-200464190-00003 · Cited by 76
Margaglione, M., Grandone, E., Vecchione, G., Cappucci, G., Giuliani, N., Colaizzo, D., Celentano, E., Panico, S., & Minno, G. D. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2082 · Cited by 77
Tani, T., Uehara, K., Sudo, T., Marukawa, K., Yasuda, Y., & Kimura, Y. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00480-3 · Cited by 76
Atherogenic dyslipidemia: Lipoprotein abnormalities and implications for therapy
Grundy, S. M. (1995) · The American Journal of Cardiology · doi:10.1016/0002-9149(95)80011-g · Cited by 76
Connelly, P. W., MacLean, D. R., Horlick, L., O'Connor, B., Petrasovits, A., & Little, J. A. (1992) · Europe PMC (PubMed Central) · Cited by 76
McKenney, J. M., McCormick, L. S., Weiss, S. R., Koren, M. J., Kafonek, S. D., & Black, D. M. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00311-2 · Cited by 75
Pihlajamäki, J., Karjalainen, L., Karhapää, P., Vauhkonen, I., Taskinen, M., Deeb, S. S., & Laakso, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1789 · Cited by 71
Austin, M. A., Talmud, P. J., Luong, L.-A., Haddad, L., Day, I. N. M., Newman, B. M., Edwards, K. L., Krauss, R. M., & Humphries, S. E. (1998) · The American Journal of Human Genetics · doi:10.1086/301712 · Cited by 72
Self-citationLipoprotein abnormalities related to women’s health
Bittner, V. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02637-1 · Cited by 72
PASSCLAIM - Diet-related cardiovascular disease
Mensink, R. P., Aro, A., Hond, E. D., German, J. B., Griffin, B. A., ten Meer, H.-U., Mutanen, M. L., Pannemans, D. L. E., & Stahl, W. (2003) · European Journal of Nutrition · doi:10.1007/s00394-003-1102-2 · Cited by 72
Determinants of Plasma HDL-Cholesterol in Hypertriglyceridemic Patients
Tatò, F., Vega, G. L., & Grundy, S. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.56 · Cited by 72
Lipid‐lowering properties of TAK‐475, a squalene synthase inhibitor, in vivo and in vitro
Nishimoto, T., Amano, Y., Tozawa, R., Ishikawa, E., Imura, Y., Yukimasa, H., & Sugiyama, Y. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705332 · Cited by 71
“Many epidemiological studies, including the Framingham Heart Study, have established an association between dyslipidemia and increased risk of coronary heart disease (CHD) (Gordon et al., 1981; Anderson et al., 1987).”
BackgroundInfluentialKatsuya, T., Horiuchi, M., Chen, Y. I., Koike, G., Pratt, R. E., Dzau, V. J., & Reaven, G. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.6.779 · Cited by 71
New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis
Beisiegel†, U. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05792-7 · Cited by 71
Effects of Fish Oil on Oxidation Resistance of VLDL in Hypertriglyceridemic Patients
Hau, M. F., Smelt, A. H. M., Bindels, A. J. G. H., Sijbrands, E. J. G., van der Laarse, A., Onkenhout, W., van Duyvenvoorde, W., & Princen, H. M. G. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.9.1197 · Cited by 71
Fruits and vegetables moderate lipid cardiovascular risk factor in hypertensive patients.
Adebawo, O. O., Salau, B. A., Ezima, E. N., Oyefuga, O., Ajani, E. O., Idowu, G. O., Famodu, A. A., & Osilesi, O. (2006) · Lipids in Health and Disease · doi:10.1186/1476-511x-5-14 · Cited by 70
Dietary Fish Oil (4 g Daily) and Cardiovascular Risk Markers in Healthy Men
Marckmann, P., Bladbjerg, E., & Jespersen, J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3384 · Cited by 70
Williamson, E. D. (2000) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(200002)14:1
Båvenholm, P. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0752 · Cited by 67
Dietary ethanol is associated with reduced lipolysis of intestinally derived lipoproteins.
Pownall, H. J. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39917-x · Cited by 66
Prescribing Aerobic Exercise for the Regulation of Postprandial Lipid Metabolism
Katsanos, C. S. (2006) · Sports Medicine · doi:10.2165/00007256-200636070-00001 · Cited by 66
Metadata
- Authors
- Austin, M. A.
- Affiliations
- University of Washington (US)
- Corresponding author
- Austin, M A
- Venue
- Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Published
- 1991-01
- Volume
- 11
- Issue
- 1
- Pages
- 2-14
- ISSN
- 1049-8834 (ISSN-L)
- OpenAlex
- W2155238815
- Cited by
- 697
- References
- 98
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 5 · 2014: 5 · 2013: 13 · 2012: 8
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arteriosclerosis and Thrombosis A Journal of Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r29hl038760-03)
- National Heart, Lung, and Blood Institute (HL38760, P01HL030086, HL3-0086)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- plasma triglycerides, coronary artery disease, cardiovascular risk factors, hypertriglyceridemia, familial hypertriglyceridemia, small dense LDL, HDL cholesterol, genetic susceptibility, primary prevention, lipid-lowering intervention
- MeSH terms
- Coronary Disease, Female, Humans, Male, Pedigree, Triglycerides, Multivariate Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review